The initiative led by government affairs was triggered by unexpectedly low penetration rates of the therapy in multiple EU countries. The initiative aimed to assemble evidence on systemic access barriers leading to patient drop-off along the patient journey, to identify root causes of the barriers, and to initiate collaborations amongst healthcare stakeholders to co-develop solutions.
We examined existing public and internal data to understand where patients are lost along the patient journey. We hypothesized different barriers that may exist at the points at which high numbers of patients were dropping out.
We identified and validated the systemic issues with external stakeholders and identified several root causes along the patient journey across multiple countries.
After validating the root causes for the systemic issues, solutions ideas were discussed by the multi-stakeholder panel.
